Stock Report

All about this stock under one free report Last Updated: 01-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Terns Pharmaceuticals (TERN) Key Ratios

Stock Card factsheet share-fund-plan-icon

$52.95

up-down-arrow $52.15 (6,518.75%)

As on 15-May-2026 16:00EDT

Market cap

info icon

$6,117 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

6.1

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -- -- --
EBIT -38.59 -31.33 -8.10 -39.21 -199.48
Net Profit 4.32 -8.13 -8.28 -25.97 -205.31
EPS 5.82 -5.89 7.18 12.55 2.78
Book Value -- -- 185.00 28.74 31.66
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsDec-25Dec-24Dec-23
EBIT-Margin info ---4,986.00------
Net Margin info ---2,955.19------
Return on equity info -25.89-29.82-14.23-29.56-33.89
Return on Capital info -25.81-29.29-14.20-29.46-33.78
Return on Assets info -24.81-27.90-13.85-28.10-32.48
Debt to Equity (x) info ----0.000.000.00

Profitability

View Detailed Peer Comparison

ROCE

-14.20

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Terns Pharmaceuticals (TERN)
-14.20
-29.46
-33.78
-27.53
-41.49
Peer Median
--
--
--
--
--
ROE

-14.23

--

Profit after tax / Average Net worth * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Terns Pharmaceuticals (TERN)
-14.23
-29.56
-33.89
-27.60
-43.83
Peer Median
--
--
--
--
--
ROA

-13.85

--

Profit after tax / Average Total assets * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Terns Pharmaceuticals (TERN)
-13.85
-28.10
-32.48
-26.52
-38.53
Peer Median
--
--
--
--
--
EBIT Margin

--

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Terns Pharmaceuticals (TERN)
--
--
--
--
-4,986.00
Peer Median
--
--
--
--
--
Net Margin

--

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Terns Pharmaceuticals (TERN)
--
--
--
-2,955.19
-5,015.80
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

--

--

Year on year growth in net sales

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Terns Pharmaceuticals (TERN)
--
--
--
-1.00
--
Peer Median
--
--
--
--
--
EBIT Growth

--

--

Year on year growth in operating profit (EBIT)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Terns Pharmaceuticals (TERN)
--
0.67
-65.34
-24.41
-34.67
Peer Median
--
--
--
--
--
Net Profit Growth

-8.28

--

Year on year growth in profit after tax

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Terns Pharmaceuticals (TERN)
-8.28
1.50
-49.49
-20.31
-70.88
Peer Median
--
--
--
--
--
EPS Growth

-0.06

--

Year on year growth in earnings per share

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Terns Pharmaceuticals (TERN)
-0.06
0.22
-0.13
0.44
-0.70
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.00

--

Total debt / Net worth

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Terns Pharmaceuticals (TERN)
0.00
0.00
0.00
0.00
--
Peer Median
--
--
--
--
--
Short term debt to equity ratio

0.00

--

(Short term borrowings / Net worth)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Terns Pharmaceuticals (TERN)
0.00
0.00
0.00
0.00
--
Peer Median
--
--
--
--
--
Current Ratio

62.41

--

Current Assets / Current Liabilities and Provisions

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Terns Pharmaceuticals (TERN)
62.41
23.14
22.39
33.68
24.48
Peer Median
--
--
--
--
--
Quick Ratio

--

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Terns Pharmaceuticals (TERN)
--
--
--
--
--
Peer Median
--
--
--
--
--
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Terns Pharmaceuticals (TERN)
--
--
--
-30.38
-69.06
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Asset Turnover

--

--

Sales / Average Total Assets

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Terns Pharmaceuticals (TERN)
--
--
--
--
0.01
Peer Median
--
--
--
--
--
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Terns Pharmaceuticals (TERN)
--
--
--
--
4,645.25
Peer Median
--
--
--
--
--
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Terns Pharmaceuticals (TERN)
--
--
--
--
2,115.88
Peer Median
--
--
--
--
--
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Terns Pharmaceuticals (TERN)
--
--
862.34
667.32
1,091.83
Peer Median
--
--
--
--
--
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Terns Pharmaceuticals (TERN)
--
--
--
--
5,669.30
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

-39.12

--

Current share price divided by earning per share in the last twelve months

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Terns Pharmaceuticals (TERN)
-39.12
-5.69
-5.20
-9.23
-3.56
Peer Median
--
--
--
--
--
Price / Book Value

3.74

--

Current share price divided by book value per share in the latest financial year

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Terns Pharmaceuticals (TERN)
3.74
1.46
1.84
2.01
1.11
Peer Median
--
--
--
--
--
EV/EBITDA

-24.93

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Terns Pharmaceuticals (TERN)
-24.93
-1.47
-2.03
-4.51
-0.26
Peer Median
--
--
--
--
--
loading...
loading...